dc.creatorMontero-Padilla, Soledad
dc.creatorVelaga, Sitaram
dc.creatorMorales, Javier O.
dc.date.accessioned2018-12-20T15:13:13Z
dc.date.available2018-12-20T15:13:13Z
dc.date.created2018-12-20T15:13:13Z
dc.date.issued2017
dc.identifierAAPS PharmSciTech, Volumen 18, Issue 2, 2018, Pages 273-282
dc.identifier15309932
dc.identifier10.1208/s12249-016-0567-2
dc.identifierhttp://repositorio.uchile.cl/handle/2250/158545
dc.description.abstract© 2016, American Association of Pharmaceutical Scientists. The development of an appropriate dosage form for pediatric patients needs to take into account several aspects, since adult drug biodistribution differs from that of pediatrics. In recent years, buccal administration has become an attractive route, having different dosage forms under development including tablets, lozenges, films, and solutions among others. Furthermore, the buccal epithelium can allow quick access to systemic circulation, which could be used for a rapid onset of action. For pediatric patients, dosage forms to be placed in the oral cavity have higher requirements for palatability to increase acceptance and therapy compliance. Therefore, an understanding of the excipients required and their functions and properties needs to be particularly addressed. This review is focused on the differences and requirements relevant to buccal administration for pediatric patients (compared to adults) and how novel dosage forms
dc.languageen
dc.publisherSpringer New York LLC
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceAAPS PharmSciTech
dc.subjectbuccal delivery
dc.subjectmucoadhesion
dc.subjectpediatric dosage forms
dc.subjectpediatric films
dc.subjectpediatric tablets
dc.subjecttransmucosal
dc.titleBuccal Dosage Forms: General Considerations for Pediatric Patients
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución